Search





Search





Markets
/
Stocks
/
prme
/

Prime Medicine Inc

PRME

Add to Watchlist

3.040USD

+0.030+1.00%

Close 07-27 16:00（ET）Quotes delayed by 15 min

549.07MMarket Cap

LossP/E TTM

Prime Medicine Inc

3.040

+0.030+1.00%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

PRME Cash Flow Statement

You can access the annual and quarterly cash flow statements of Prime Medicine Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

Operating cash flows (indirect method)

Cash flow from continuing operating activities

12.58%-42.71M

-329.34%-37.26M

-35.22%-35.04M

8.97%-41.41M

27.84%-48.86M

137.03%16.25M

33.84%-25.91M

-11.44%-45.49M

-62.91%-67.71M

-42.82%-43.86M

-30.13%-39.17M

-101.85%-40.82M

18.18%-41.56M

-132.90%-30.71M

-213.33%-30.10M

-215.39%-20.22M

-941.48%-50.79M

-430.45%-13.19M

---9.61M

---6.41M

---4.88M

---2.49M

Net income from continuing operations

5.33%-49.12M

-9.00%-46.08M

3.69%-50.58M

4.95%-52.59M

-13.39%-51.89M

35.60%-42.28M

-3.57%-52.52M

-30.53%-55.33M

-16.15%-45.76M

-67.10%-65.64M

-72.77%-50.71M

-44.42%-42.38M

-65.26%-39.40M

37.56%-39.28M

-78.83%-29.35M

-4864.29%-29.35M

72.49%-23.84M

-2352.67%-62.91M

---16.41M

--616.00K

---86.66M

---2.56M

Operating gains losses

9.18%1.86M

9.26%1.88M

20.73%1.88M

21.20%1.86M

29.28%1.70M

37.69%1.72M

26.05%1.56M

37.57%1.54M

25.00%1.31M

43.33%1.25M

95.88%1.24M

160.00%1.12M

259.04%1.05M

279.91%870.00K

277.84%631.00K

252.46%430.00K

486.00%293.00K

895.65%229.00K

--167.00K

--122.00K

--50.00K

--23.00K

Deferred tax

----

100.00%0.00

-100.00%0.00

--0.00

100.00%0.00

-532.26%-134.00K

166.34%134.00K

100.00%0.00

-150.94%-108.00K

107.01%31.00K

62.03%-202.00K

-116.25%-202.00K

108.95%212.00K

-139.53%-442.00K

13.50%-532.00K

-33.42%1.24M

---2.37M

--1.12M

---615.00K

--1.87M

Other non-cash items

17.82%2.84M

17.89%2.60M

4.66%2.33M

-48.61%2.35M

-27.93%2.41M

-34.05%2.21M

-28.89%2.23M

31.56%4.57M

18.26%3.35M

19.66%3.35M

13.21%3.14M

41.93%3.47M

59.49%2.83M

-79.12%2.80M

130.26%2.77M

135.29%2.45M

-97.83%1.77M

49.45%13.40M

--1.20M

--1.04M

--81.67M

--8.97M

Change in working capital

67.33%-2.50M

-97.63%1.16M

-96.43%609.00K

111.54%548.00K

74.58%-7.65M

238.13%48.86M

611.80%17.08M

14.98%-4.75M

-249.48%-30.11M

1133.99%14.45M

162.34%2.40M

-456.70%-5.59M

74.87%-8.62M

-96.29%1.17M

-393.33%-3.85M

552.50%1.57M

-22222.58%-34.29M

131604.17%31.56M

---780.00K

--240.00K

--155.00K

---24.00K

-Change in receivables

100.00%0.00

----

100.22%120.00K

---103.00K

---17.00K

--55.00M

---55.00M

----

-Change in prepaid expenses

254.75%1.22M

140.61%2.60M

118.67%1.30M

424.00%1.44M

71.76%-789.00K

-1440.48%-6.39M

-85.70%-6.95M

106.85%275.00K

-117.43%-2.79M

36.93%-415.00K

-260.75%-3.74M

-1098.21%-4.01M

-540.07%-1.28M

-170.78%-658.00K

-171.47%-1.04M

-20.50%-335.00K

1522.22%292.00K

-250.00%-243.00K

---382.00K

---278.00K

--18.00K

--162.00K

-Change in other current liabilities

40.47%-856.00K

53.33%-751.00K

-101.63%-1.18M

---995.00K

---1.44M

---1.61M

--71.92M

----

Cash from non-recurring investing activities

Cash from operating activities

12.58%-42.71M

-329.34%-37.26M

-35.22%-35.04M

8.97%-41.41M

27.84%-48.86M

137.03%16.25M

33.84%-25.91M

-11.44%-45.49M

-62.91%-67.71M

-42.82%-43.86M

-30.13%-39.17M

-101.85%-40.82M

18.18%-41.56M

-132.90%-30.71M

-213.33%-30.10M

-215.39%-20.22M

-941.48%-50.79M

-430.45%-13.19M

---9.61M

---6.41M

---4.88M

---2.49M

Investing cash flow

Net cash from continuing investing activities

-91.16%214.00K

-83.81%290.00K

-80.66%247.00K

-17.35%1.57M

4.22%2.42M

-2.66%1.79M

-56.10%1.28M

-3.74%1.90M

16.26%2.32M

-61.78%1.84M

-39.28%2.91M

-58.85%1.98M

18.42%2.00M

1160.21%4.81M

162.66%4.79M

418.57%4.80M

65.82%1.69M

29.05%382.00K

--1.82M

--926.00K

--1.02M

--296.00K

Capital expenditures

-91.16%214.00K

-83.81%290.00K

-80.66%247.00K

-17.35%1.57M

4.22%2.42M

-2.66%1.79M

-56.10%1.28M

-3.74%1.90M

16.26%2.32M

-61.78%1.84M

-39.28%2.91M

-58.85%1.98M

18.42%2.00M

1160.21%4.81M

162.66%4.79M

418.57%4.80M

65.82%1.69M

29.05%382.00K

--1.82M

--926.00K

--1.02M

--296.00K

Net cash flow from disposal of fixed assets

-91.16%214.00K

-83.81%290.00K

-80.66%247.00K

-17.35%1.57M

4.22%2.42M

-2.66%1.79M

-56.10%1.28M

-3.74%1.90M

16.26%2.32M

-61.78%1.84M

-39.28%2.91M

-58.85%1.98M

18.42%2.00M

1160.21%4.81M

162.66%4.79M

418.57%4.80M

65.82%1.69M

29.05%382.00K

--1.82M

--926.00K

--1.02M

--296.00K

Net cash flow from investment products

196.22%43.60M

-42.81%28.62M

-277.99%-91.88M

-50.63%4.34M

-30.58%-45.32M

16.04%50.04M

248.07%51.62M

-70.52%8.80M

-225.41%-34.71M

586.03%43.13M

-299.78%-34.86M

164.88%29.84M

-132.74%-10.67M

-170.78%-8.87M

-50.03%-8.72M

39.68%-45.99M

70728.26%32.58M

20993.33%12.54M

---5.81M

---76.25M

--46.00K

---60.00K

Net cash flow from other investing activities

----

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

190.89%43.39M

-41.29%28.33M

-282.99%-92.12M

-59.81%2.77M

-28.92%-47.74M

16.88%48.25M

233.29%50.34M

-75.26%6.89M

-192.40%-37.03M

401.64%41.28M

-179.55%-37.77M

154.85%27.86M

-141.00%-12.66M

-212.61%-13.69M

-76.94%-13.51M

34.18%-50.79M

3278.29%30.89M

3514.04%12.15M

---7.64M

---77.17M

---972.00K

---356.00K

Financing cash flow

Cash flow from continuous financing activities

-93.45%393.00K

56100.00%562.00K

275.85%144.75M

462.86%197.00K

-96.19%6.00M

-99.48%1.00K

12011.01%38.51M

-53.33%35.00K

231263.24%157.33M

-99.89%194.00K

146.56%318.00K

112.02%75.00K

105.35%68.00K

17049.63%184.07M

-68200.00%-683.00K

-100.23%-624.00K

-154.99%-1.27M

-103.11%-1.09M

---1.00K

--268.05M

--2.31M

--34.95M

Net cash flow from common stock issuance/repurchase

----

15300.00%154.00K

259.61%138.38M

--197.00K

-100.00%0.00

--1.00K

--38.48M

--0.00

--132.49M

----

--185.32M

----

--0.00

Net cash flow from preferred stock issuance/repurchase

----

100.00%0.00

-100.00%0.00

---1.00K

--268.05M

--2.31M

--34.95M

Proceeds from stock option exercised by employees

--393.00K

--408.00K

1065.63%373.00K

-100.00%0.00

-89.94%32.00K

-53.33%35.00K

-47.06%36.00K

24.36%194.00K

404.76%318.00K

--75.00K

--68.00K

--156.00K

--63.00K

----

Proceeds from issuance of warrants

----

--0.00

-100.00%0.00

--0.00

--18.80M

----

Net cash flow from other financing activities

-100.00%0.00

--0.00

--6.00M

--0.00

0.00%6.00M

--0.00

--6.00M

100.00%0.00

-28.91%-1.40M

---746.00K

---624.00K

---1.27M

---1.09M

--0.00

Net cash from non-recurrent financing activities

Net cash from financing activities

-93.45%393.00K

56100.00%562.00K

275.85%144.75M

462.86%197.00K

-96.19%6.00M

-99.48%1.00K

12011.01%38.51M

-53.33%35.00K

231263.24%157.33M

-99.89%194.00K

146.56%318.00K

112.02%75.00K

105.35%68.00K

17049.63%184.07M

-68200.00%-683.00K

-100.23%-624.00K

-154.99%-1.27M

-103.11%-1.09M

---1.00K

--268.05M

--2.31M

--34.95M

Net cash flow

Beginning cash balance

-60.96%76.72M

-35.56%85.09M

-2.32%67.50M

-1.60%105.94M

256.89%196.54M

129.81%132.04M

-48.46%69.10M

-26.74%107.66M

-72.62%55.07M

-6.49%57.45M

26.80%134.07M

-17.15%146.96M

1.29%201.12M

-69.38%61.44M

-51.48%105.73M

430.44%177.37M

436.97%198.54M

4026.34%200.66M

--217.91M

--33.44M

--36.98M

--4.86M

Current period cash flow changes

101.19%1.07M

-112.97%-8.36M

-72.05%17.59M

0.31%-38.44M

-272.28%-90.60M

2804.36%64.50M

182.15%62.94M

-199.28%-38.56M

197.10%52.59M

-101.71%-2.38M

-72.98%-76.62M

82.01%-12.88M

-155.80%-54.16M

6691.46%139.67M

-156.87%-44.29M

-138.83%-71.64M

-498.76%-21.17M

-106.60%-2.12M

---17.24M

--184.47M

---3.54M

--32.11M

Ending cash balance

-26.56%77.80M

-60.96%76.72M

-35.56%85.09M

-2.32%67.50M

-1.60%105.94M

256.89%196.54M

129.81%132.04M

-48.46%69.10M

-26.74%107.66M

-72.62%55.07M

-6.49%57.45M

26.80%134.07M

-17.15%146.96M

1.29%201.12M

-69.38%61.44M

-51.48%105.73M

430.44%177.37M

436.97%198.54M

--200.66M

--217.91M

--33.44M

--36.98M

Free cash flow

16.29%-42.92M

-359.76%-37.55M

-29.78%-35.29M

9.30%-42.98M

26.78%-51.28M

131.63%14.45M

35.38%-27.19M

-10.74%-47.39M

-60.77%-70.03M

-28.65%-45.70M

-20.60%-42.08M

-71.02%-42.80M

17.00%-43.56M

-161.82%-35.53M

-205.24%-34.89M

-241.03%-25.02M

-790.26%-52.48M

-387.74%-13.57M

---11.43M

---7.34M

---5.89M

---2.78M

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Prime Medicine Inc Generate?



Prime Medicine Inc generated -162.56M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Prime Medicine Inc's Operating Cash Flow Change Year Over Year?



Prime Medicine Inc's operating cash flow increased by -32.31% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does Prime Medicine Inc Spend on Capital Expenditures?



Prime Medicine Inc spent 4.53M on capital expenditures in the most recent quarter。

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Prime Medicine Inc's Financing Cash Flow Changed?



Prime Medicine Inc used 151.51M in financing activities in the latest quarter.

What is free cash flow and why does it matter for PRME?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Prime Medicine Inc’s free cash flow in the latest quarter?



Free cash flow was -167.09M reflecting a -28.38% change from the previous year.